Search Results - "Gatter, Ken M"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios can Predict Treatment Response to Neoadjuvant Therapy in Esophageal Cancer by McLaren, Patrick J., Bronson, Nathan W., Hart, Kyle D., Vaccaro, Gina M., Gatter, Ken M., Thomas, Charles R., Hunter, John G., Dolan, James P.

    Published in Journal of gastrointestinal surgery (01-04-2017)
    “…Introduction We hypothesized that serum neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios may predict pathologic complete response to neoadjuvant…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Drug resistance in B‐cell chronic lymphocytic leukemia: Predictable by in vitro evaluation with a multiparameter flow cytometric cytotoxicity assay by Zhong, Yanping, Bakke, Antony C., Fan, Guang, Braziel, Rita M., Gatter, Ken M., Leis, Jose F., Maziarz, Richard T., Huang, James Z.

    Published in Cytometry. Part B, Clinical cytometry (01-05-2007)
    “…Background: Patients with B‐cell chronic lymphocytic leukemia (B‐CLL) often demonstrate variable responses to similar treatments. It would be highly desirable…”
    Get full text
    Journal Article
  6. 6

    The big problem of the missing cytology slides by Gatter, Ken

    Published in CytoJournal (24-09-2004)
    “…Cytology slides are often unique and irreplaceable. Unlike surgical pathology cases, where additional paraffin sections can be cut, cytology slides often…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Fine-needle aspiration biopsy of anaplastic large cell lymphoma, small cell variant with prominent plasmacytoid features: Case report by Gatter, Ken M., Rader, Anne, Braziel, Rita M.

    Published in Diagnostic cytopathology (01-02-2002)
    “…Anaplastic large cell lymphoma (ALCL), according to the new WHO classification, is a diagnosis limited to T/NK cell lymphomas. We present a case that…”
    Get full text
    Journal Article
  9. 9

    Trisomy 8 as the sole cytogenetic abnormality in a case of extraskeletal mesenchymal chondrosarcoma by Gatter, Ken M., Olson, Susan, Lawce, Helen, Rader, Anne E.

    Published in Cancer genetics and cytogenetics (01-06-2005)
    “…Mesenchymal chondrosarcoma is a rare malignant tumor that comprises about 3–10% of all sarcomas. Reports of cytogenetic studies of mesenchymal chondrosarcoma…”
    Get full text
    Journal Article
  10. 10

    A Novel Multiparameter Flow Cytometric Cytotoxicity Assay Detects p53 Deletion as the Major Cause of In Vitro Resistance to Fludarabine in B-Cell Chronic Lymphocytic Leukemia by Huang, James Z., Bakke, Antony C., Fan, Guang, Braziel, Rita, Gatter, Ken M., Maziarz, Richard T., Leis, Jose F., Zhong, Yanping

    Published in Blood (16-11-2005)
    “…Individual patients with B-CLL demonstrate variable responses to standard induction and salvage therapeutic regimens. It would be highly desirable to develop a…”
    Get full text
    Journal Article
  11. 11